New Haven biotech to create new subsidiary focused on cancer drugs
BioXcel Therapeutics is creating a wholly-owned subsidiary focused on developing cancer-fighting drugs using artificial intellegece. |!| New Haven
More from Greater New Haven
New Haven Register
New Haven man pleads guilty to lying to IRS in $257K COVID-19 fraud scheme
Greater New Haven
•
8h ago
Post Eagles
Volleyball claims third-straight victory in five-set showdown to open Homecoming Weekend
Greater New Haven
•
8h ago
New Haven Register
Footage shows Yale officer shooting through car window during rescue attempt in New Haven
Greater New Haven
•
10h ago
New Haven Register
Former Connecticut state marshal arrested for stealing $38K in garnished funds, officials say
Greater New Haven
•
10h ago
New Haven Register
Strong storms, isolated tornado possible in Connecticut tonight. Here's when
Greater New Haven
•
11h ago
New Haven Register
Four Connecticut universities are waiving the $50 fee to apply for fall 2027
Greater New Haven
•
11h ago